Koppers (KOP)
(Delayed Data from NYSE)
$38.97 USD
+0.20 (0.52%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $38.96 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.97 USD
+0.20 (0.52%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $38.96 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum B VGM
Zacks News
Royal Gold (RGLD) Q3 Earnings Miss Estimates, Increase Y/Y
by Zacks Equity Research
Royal Gold (RGLD) Q3 top-line results reflect the impacts of higher gold, silver and copper prices, and increased gold production at the Cortez Legacy Zone.
Cabot's (CBT) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
The decline in sales of Cabot's (CBT) Reinforcement Materials unit is due to reduced sales in the Americas and EMEA in the fiscal fourth quarter.
Air Products' (APD) Q4 Earnings Top Estimates on Higher Prices
by Zacks Equity Research
Higher pricing and increased equity affiliates' income drive Air Products' (APD) bottom line in Q4.
DuPont (DD) Opens New Kalrez Manufacturing Site in Delaware
by Zacks Equity Research
The new Tralee Park Annex facility will significantly increase DuPont (DD) Kalrez perfluoroelastomer components capacity.
Hawkins (HWKN) Earnings Beat Estimates in Q2, Revenues Lag
by Zacks Equity Research
Lower sales across Hawkins' (HWKN) Industrial and Health and Nutrition segments more than offset gains in the Water Treatment unit in Q2.
Steel Dynamics (STLD) Declares $1.5B Share Buyback Authorization
by Zacks Equity Research
Steel Dynamics' (STLD) strong operational model, capital structure and liquidity profile provide the required capacity to grow strategically and generate value for shareholders.
ATI's Q3 Earnings & Sales Top on Aerospace and Defense Strength
by Zacks Equity Research
ATI benefits from continued sales growth in aerospace and defense markets in the third quarter.
Westlake's (WLK) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Westlake (WLK) benefits from resilient North American housing and infrastructure construction activities and higher operating rates despite lower average sales prices in Q3.
Kronos Worldwide's (KRO) Q3 Earnings and Sales Miss Estimates
by Zacks Equity Research
The decline in the bottom line of Kronos (KRO) is primarily due to lower sales volumes and average TiO2 selling prices in Q3.
3 Intriguing Stocks to Consider as Earrings Approach
by Shaun Pruitt
With optimism springing in markets today on the back of the Fed leaving rates unchanged, several intriguing companies are set to report third quarter results on Friday, November 3 with now looking like a good time to buy their stocks.
CF Industries' (CF) Q3 Earnings Miss, Lower Prices Hurt Sales
by Zacks Equity Research
Lower average selling prices resulting from increased global supply availability hurt CF Industries' (CF) top line in Q3.
Ingevity's (NGVT) Earnings and Sales Miss Estimates in Q3
by Zacks Equity Research
Lower volumes due to weak industrial demand hurt Ingevity's (NGVT) Advanced Polymer Technologies and the Industrial Specialties business lines in Q3.
Scotts Miracle-Gro (SMG) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
The decline in sales of Scotts Miracle-Gro (SMG) is due to lower sales in the U.S. Consumer and Hawthorne segments in Q4.
Southern Copper (SCCO) Q3 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Southern Copper's (SCCO) third-quarter 2023 results reflect higher prices for molybdenum, silver and copper.
VALE (VALE) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Vale (VALE) reports year-over-year growth in third-quarter 2023 revenues on higher iron ore and copper sales volume, and increased average realized prices for iron ore and copper.
Huntsman's (HUN) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Huntsman's (HUN) revenues decline in Q3 owing to lower average selling price, low sales volume and adverse sales mix.
Carpenter Technology (CRS) Earnings Beat Estimates in Q1
by Zacks Equity Research
Carpenter Technology's (CRS) Q1 results reflect a solid end-use market performance.
FMC (FMC) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
FMC lags Q3 estimates amid lower sales in Latin America, channel destocking in all regions
Reliance Steel (RS) Q3 Earnings Miss, Revenues Top Estimates
by Zacks Equity Research
Reliance Steel (RS) revenues top estimates in Q3 due to an increase in volumes.
Chemours (CC) Q3 Earning Miss, Titanium Technologies Hurt Sales
by Zacks Equity Research
Chemours (CC) lags estimates in Q3 amid lower volumes and soft demand.
Olin (OLN) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
The top line of Olin (OLN) is hurt by lower volumes in its chemical businesses in Q3.
Element (ESI) Q3 Earnings Surpass Estimates, Revenues Lag
by Zacks Equity Research
Element's (ESI) third-quarter earnings top estimates on improved margins.
LyondellBasell's (LYB) Q3 Earnings and Sales Beat Estimates
by Zacks Equity Research
Strong oxyfuels margins contribute to record EBITDA in LyondellBasell's (LYB) Intermediates & Derivatives segment in the third quarter.
U.S. Steel's (X) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
U.S. Steel (X) benefits from diverse order book, flat-rolled product portfolio and cost actions in the third quarter.
Eastman Chemical (EMN) Q3 Earnings & Sales Beat Estimates
by Zacks Equity Research
Revenues of Eastman Chemical (EMN) decline in Q3 primarily due to lower sales volume and reduced selling prices.